Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




New Material Aids Facial Skin Reconstruction

By HospiMedica International staff writers
Posted on 11 Aug 2011
An injectable composite of biological and synthetic molecules shows promise in restoring damaged soft tissue relatively safely and durably. More...


Researchers at Johns Hopkins University (Baltimore, MD, USA) created the new composite material from hyaluronic acid (HA), a natural component in skin of young people that confers elasticity, and polyethylene glycol (PEG), a synthetic molecule used successfully as surgical glue in operations and known not to cause severe immune reactions. The PEG can be cross-linked-- forming sturdy chemical bonds between many individual molecules--using energy from light, which traps the HA molecules with it. Such cross-linking makes the implant hold its shape and not dissipate away from the injection site.

To develop the best PEG-HA composite with the highest long-term stability, the researchers injected different concentrations of PEG and HA under the skin and into the back muscle of rats, used a green light emitting diode (LED) light to gel the material, and then used magnetic resonance imaging (MRI) to monitor the persistence of the implant over time. The MRIs and direct measurements of the implants showed that the ones created from HA and the highest tested concentration of PEG with HA remained the same size over time, compared to injections of only HA, which shrank over time.

The researchers also evaluated the safety and persistence of the PEG-HA implants in three volunteers undergoing abdominoplasty. Technicians injected about five drops of PEG-HA or HA alone under the belly skin. The participants said they sensed heat and pain during the gel setting process; 12 weeks after implantation, MRI revealed no loss of implant size in patients. Removal of the implants and inspection of the surrounding tissue revealed mild to moderate inflammation, a response similar to that seen in the rats, although the types of white blood cells (WBCs) responding to implant differed between the rodents and humans. The difference was attributed to the fact that the target tissue in the rats (muscle) was different than human belly fat. The study was published in the July 27, 2011, issue of Science Translational Medicine.

“Implanted biological materials can mimic the texture of soft tissue, but are usually broken down by the body too fast, while synthetic materials tend to be more permanent but can be rejected by the immune system and typically don’t meld well with surrounding natural tissue,” said lead author Prof. Jennifer Elisseeff, MD, PhD, director of the Translational Tissue Engineering Center at JHU School of Medicine. “Our composite material has the best of both worlds, with the biological component enhancing compatibility with the body and the synthetic component contributing to durability.”

“Many of the skin fillers available on the market consisting of HA-like materials used for face lifts are only temporarily effective, and are limited in their ability to resculpt entire areas of the face,” added Professor Elisseeff. “Our hope is to develop a more effective product for people, like our war veterans, who need extensive facial reconstruction.”

Related Links:

Johns Hopkins University


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.